Cefozopran
Cefozopran (SCE-2787) is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran, an antibiotic, has a broad spectrum of antibacterial activity, inhibiting most of the gram-negative and gram-positive organisms[1][2].
Product Specifications
CAS Number
113359-04-9
Product Name Alternative
SCE-2787
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cefozopran.html
Solubility
10 mM in DMSO
Smiles
[O-]C(C(N1[C@@]2([H])[C@H](NC(/C(C3=NSC(N)=N3)=N\OC)=O)C1=O)=C(CS2)C[N+]4=C(C=CC=N5)N5C=C4)=O
Molecular Formula
C19H17N9O5S2
Molecular Weight
515.53
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501
References & Citations
[1]Sato T, et al. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders. Pediatr Blood Cancer. 2008;51 (6) :774-777.|[2]Iizawa Y, et al. Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice. Antimicrob Agents Chemother. 1993;37 (1) :100-105.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
β-lactam
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS083987-100ug 100 µg
CCDC8 (NM_032040) Human Over-expression Lysate
Sign In for Pricing
View Details A02555-Fluoro647 100 µg/Vial
Anti-AGL Antibody Picoband® Fluoro647 Conjugated
Sign In for Pricing
View Details 
